Omacor Reliant Pharmaceuticals, Inc. - Treatment for Hypertriglyceridemia
Omacor, which contains highly concentrated ethyl esters of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), is indicated as an adjunct to diet for the reduction of triglycerides in adult patients with very high triglyceride levels.Posted: November 2004
Omacor (omega-3-acid ethyl esters) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
